Top Markets
#1 Akedo Akedo +61.77%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.05%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.60%
#6 τemplar τemplar +27.06%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.57%
#8 Bitway Bitway +17.22%
#9 Perle Perle +16.80%
#10 Cap Cap +16.64%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Visioneering Technologies, Inc. Visioneering Technologies, Inc.

Visioneering Technologies, Inc.

VTI
Classement en actions #38209
Visioneering Technologies, Inc. is a medical device company focused on the... Visioneering Technologies, Inc. is a medical device company focused on the development, production, marketing, and distribution of contact lenses. Its commercial activities extend across North America, Europe, and the Asia-Pacific regions. The company's primary offering is NaturalVue, a multifocal contact lens engineered to help adults experiencing presbyopia and children with myopia. Visioneering Technologies was established in 2008 and has its main office situated in Alpharetta, Georgia.
Prix de l'action
$0.04200239
Dernière synchronisation: 2025-02-17
Capitalisation boursière
$1.13M
Changement (1 jour)
0.21%
Changement (1 an)
0.00%
Pays
US
Échange Visioneering Technologies, Inc. (VTI)

Catégorie

Healthcare
Revenus pour Visioneering Technologies, Inc. (VTI)
Revenus en Dec 2023 TTM : $13.04M
Selon les derniers rapports financiers de Visioneering Technologies, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $13.04M. En 2022, l'entreprise a réalisé un chiffre d'affaires de $7.29M une augmentation par rapport à le chiffre d'affaires de l'année 2021, qui était de $5.19M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Visioneering Technologies, Inc. de 2016 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $13.04M 50.45%
2023 $8.67M 19.01%
2022 $7.29M 40.49%
2021 $5.19M 32.45%
2020 $3.91M -2.72%
2019 $4.02M 57.99%
2018 $2.55M 215.25%
2017 $807.99K 286.16%
2016 $209.23K 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 357,036.09%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 197,975.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 271,932.14%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 160,862.31%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 49,825.46%
US